New eczema drug shows promise in Mid-Stage trial
NCT ID NCT07230860
First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 3 times
Summary
This study tests an experimental drug called JNJ-95597528 in 180 adults with moderate to severe atopic dermatitis (eczema). Participants will receive either the drug or a placebo to see if it improves skin symptoms by at least 75% after 12 weeks. The goal is to control the disease, not cure it, and ongoing treatment may be needed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATITIS ATOPIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Allergy Research Canada Inc.
Niagara Falls, Ontario, L2H 1H5, Canada
-
Arlington Dermatology
Rolling Meadows, Illinois, 60008, United States
-
CCA Medical Research Corporation
Ajax, Ontario, L1S7K8, Canada
-
CIPREC
Buenos Aires, C1061AAS, Argentina
-
Center for Clinical Studies
Houston, Texas, 77004, United States
-
Centro Respiratorio Infantil
Rosario, 2000, Argentina
-
Centro de Investigaciones Clinicas CIC IESR
Rosario, 2000, Argentina
-
Centro de Investigaciones Medicas Tucuman
San Miguel de Tucumán, T4000AXL, Argentina
-
Ceti - Centro de Estudos Em Terapias Inovadoras
Curitiba, 80030 110, Brazil
-
Chang Gung Memorial Hospital
Kaohsiung City, 833, Taiwan
-
China Japan Friendship Hospital
Beijing, 100029, China
-
Chung Shan Medical University Hospital
Taichung, 40201, Taiwan
-
Clinical Research Philadelphia
Philadelphia, Pennsylvania, 19114, United States
-
DOM Reumatologia
Buenos Aires, C1111, Argentina
-
Dawes Fretzin Clinical Research Group
Indianapolis, Indiana, 46250, United States
-
DermEdge Research
Mississauga, Ontario, L4Y 4C5, Canada
-
Derma Internacional S A
Buenos Aires, C1426, Argentina
-
Dermatology Research Institute Inc
Calgary, Alberta, T2J 7E1, Canada
-
Dr Wei Jing Loo Medicine Professional Corporation
London, Ontario, N6H 5L5, Canada
-
Driven Research LLC
Miami, Florida, 33126, United States
-
First OC Dermatology
Fountain Valley, California, 92708, United States
-
Fundacao do ABC Centro Universitario FMABC
Santo André, 09060 870, Brazil
-
Henry Ford Health System
Detroit, Michigan, 48202, United States
-
Hosp. of Chengde Medical University
Chengde, 067030, China
-
Hospital De Clinicas De Porto Alegre
Porto Alegre, 90035 903, Brazil
-
INAER - Investigacion en Alergias y Enfermedades Respiratorias
Buenos Aires, C1425BEN, Argentina
-
ISA - Interdisciplinary Study Association GmbH
Berlin, 10789, Germany
-
Instituto Brasil de Pesquisa Clinica
Rio de Janeiro, 20241 180, Brazil
-
Instituto Medico De Alta Complejidad (IMAC)
Buenos Aires, B1643CRO, Argentina
-
Instituto de Investigaciones Clinicas Cordoba
Córdoba, X5000AAW, Argentina
-
Jitaikai Tachikawa dermatology clinic
Tachikawa, 190 0023, Japan
-
Kaohsiung Veterans General Hospital
Kaohsiung City, 813, Taiwan
-
Kindai University Hospital
Sakai, 590 0197, Japan
-
Klinikum rechts der Isar an der Technischen Universitat Munchen
München, 80802, Germany
-
Kume Clinic
Nishiku, 593-8324, Japan
-
Linkou Chang Gung Memorial Hospital
Taoyuan, 333, Taiwan
-
Mautalen Salud e Investigacion
CABA, C1128AAF, Argentina
-
Miyata Dermatology Clinic
Matsudo, 271-0092, Japan
-
National Taiwan University Hospital
Taipei, 10048, Taiwan
-
Nomura Dermatology Clinic
Yokohama, 221 0825, Japan
-
Oregon Dermatology and Research Center
Portland, Oregon, 97210, United States
-
PSEG trials Centro de Pesquisa Clinica S A
São Paulo, 04038 002, Brazil
-
Pesquisare Saude
Santo André, 09080-110, Brazil
-
Progressive Clinical Research
San Antonio, Texas, 78213, United States
-
Red River Research Partners LLC
Fargo, North Dakota, 58103, United States
-
SOLUMED Centrum Medyczne
Poznan, 60 529, Poland
-
Sanmenxia Central Hospital
Sanmenxia, 472000, China
-
SimcoDerm Medical and Surgical Dermatology Centre
Barrie, Ontario, L4M 7G1, Canada
-
Southern California Dermatology
Santa Ana, California, 92701, United States
-
Studienzentrum an der Hase GbR
Bramsche, 49565, Germany
-
Taipei Medical University Shuang Ho Hospital
New Taipei City, 235, Taiwan
-
Teikyo University Hospital
tabashi City, 173-8606, Japan
-
The First Affiliated Hospital of Sun Yat-Sen University
Guangzhou, 510080, China
-
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, 710004, China
-
Tri-Service General Hospital
Taipei, 114202, Taiwan
-
Universitaetsklinikum Muenster
Münster, 48149, Germany
-
University of California Los Angeles - Division of Dermatology
Los Angeles, California, 90024, United States
-
West China Hospital of Sichuan University
Chengdu, 610041, China
-
Wuxi People s Hospital
Wuxi, 214100, China
-
XLR8 Medical Research
Windsor, Ontario, N8T 1E6, Canada
-
Xiangya Hospital Central South University
Changsha, 410008, China
-
York Dermatology Clinic and Research Centre
Richmond Hill, Ontario, L4B1L1, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Real-World dupixent: does it live up to the hype for eczema?
- Scientists hunt for biological clues to severe childhood eczema
- Can a drug calm severe eczema itch when the rash is mild? a new study investigates
- Eczema drug nemolizumab put to the vaccine test
- New eczema drug enters first human tests
- Eczema drug study pulled before it started